769 related articles for article (PubMed ID: 6439269)
21. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
22. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Simon MF; Chap H; Braquet P; Douste-Blazy L
Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
Violi F; Pratico D; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
[TBL] [Abstract][Full Text] [Related]
24. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
Korth R; Riess H; Brehm G; Hiller E
Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
[TBL] [Abstract][Full Text] [Related]
26. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
27. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
28. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Francesconi M; Scapin M; Casonato A; Girolami A; Deana R
Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273
[TBL] [Abstract][Full Text] [Related]
29. The role of extracellular Ca2+ and Na+ in paf-acether-induced human platelet activation.
Keraly CL; Delautier D; Benveniste J
Biochem Pharmacol; 1989 Oct; 38(20):3415-21. PubMed ID: 2818633
[TBL] [Abstract][Full Text] [Related]
30. Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?
Viero P; Cortelazzo S; Barbui T; de Gaetano G
Haemostasis; 1986; 16(1):27-33. PubMed ID: 3699584
[TBL] [Abstract][Full Text] [Related]
31. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.
Lellouch-Tubiana A; Lefort J; Pirotzky E; Vargaftig BB; Pfister A
Br J Exp Pathol; 1985 Jun; 66(3):345-55. PubMed ID: 3890915
[TBL] [Abstract][Full Text] [Related]
33. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
34. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Touqui L; Jacquemin C; Vargaftig BB
Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
[TBL] [Abstract][Full Text] [Related]
35. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Br J Clin Pharmacol; 1992 Jan; 33(1):25-31. PubMed ID: 1540486
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.
Kloprogge E; Akkerman JW
Biochem J; 1986 Dec; 240(2):403-12. PubMed ID: 3101672
[TBL] [Abstract][Full Text] [Related]
37. Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid.
Baker RC; Fish HT; Fitzpatrick FA
Alcohol Clin Exp Res; 1989 Dec; 13(6):824-8. PubMed ID: 2557776
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
[TBL] [Abstract][Full Text] [Related]
39. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
40. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen.
Vargaftig BB; Joseph D; Wal F; Marlas G; Chignard M; Chevance LG
Eur J Pharmacol; 1983 Aug; 92(1-2):57-68. PubMed ID: 6628537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
